Delivery Order SPE2DB20D2104-SPE2DB21FT97R
Award Date 9/16/21
Potential Completion Date 9/17/21
Potential Value $1.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Daliresp 250 mcg tablets to the Defense Logistics Agency (DLA). The $2,671.64 firm-fixed-price delivery order is the latest in a series of contracts between Amerisourcebergen and the DLA, with the company holding a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of DALIRESP 500 MCG TABLET 90S. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $20,496.82 and was placed as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $77,176.71 firm-fixed-price delivery order is for the pharmaceutical product Daliresp 500 mcg tablets. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is a delivery order (SPE2DB20D3505|SPE2DB24FT2W2) worth $1,099.55 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is from the Defense Logistics Agency (DLA) for the pharmaceutical product DALIRESP 500 MCG TABLET 30S. The contract has an ultimate completion date of October 25, 2023 and is a firm fixed price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,866.12 firm-fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC serves as...
- This federal contract award, valued at $18,165.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The award has a completion date of September 9, 2022 and was issued on a firm fixed-price basis. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with ID SPE2DB20D2014|SPE2DB23FC11R, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,256.66 fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product, with a performance period through May 3, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The $3,801.66 firm fixed price delivery order is for the pharmaceutical product DALIRESP 500 MCG TABLET 30S. The contract has an ultimate completion date of February 7, 2025. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DALIRESP 500 MCG TABLET 30S. The $6,097.71 firm fixed price contract is funded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of DALIRESP 500 MCG TABLET 90S. The contract has a ceiling value of $5,209.62 and runs through February 4, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...